|
|
Levaquin - Newsfeeds
-
-
May be stored at room temperature. Levofloxacin: 400 mg in 1000 ml of normal saline. Refrigerate. Use entire solution in 14 days or less. Ceftazidime: 1 g in 1000 ml of normal saline. Refrigerate. Use entire solution in 10 days or less. Nasal lavage is ...
-
-
Mpex is in the final stage of clinical testing of a proprietary inhalable formulation of levofloxacin for the treatment of microbial infections in patients with cystic fibrosis. The company's mission is to develop important new therapies to combat the ...
-
-
April D. Miller, Pharm.D.; Amanda M. Ball, Pharm.D.; P. Brandon Bookstaver, Pharm.D.; Emily K. Dornblaser, Pharm.D.; Charles L. Bennett, M.D., Ph.D. Antimicrobials are the most frequently implicated class of drugs in druginduced seizure, with ß-lactams ...
-
-
ATLANTA, April 18, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that 2011 first quarter financial results will be released on Thursday, April 28 ...
-
-
Sales of Levaquin, an antibiotic, jumped 17 percent to $434 million because of a higher incidence of flu and respiratory illness, the company said. Pfizer Inc. (PFE) , based in New York, is the largest health products maker by annual sales. To contact the ...
-
-
Sales of Concerta, used to treat attention deficit disorder, rose 10 percent to $362 million, while sales of antibiotic Levaquin rose 17 percent to $434 million. The company's biggest medicine, arthritis treatment Remicade, grew 8.3 percent to $1.29 ...
-
-
Mild cases of acute UTI may disappear on their own without treatment. However, because of the risk of the infection spreading to the kidneys (complicated UTI), treatment is usually recommended. In most cases, treatment can be done on an outpatient basis ...
-
-
Moreover, the company is about to face generic competition on two key drugs: Levaquin loses exclusivity in the US in June of 2011 and Concerta in May of 2011. I estimate that combined sales of these products will drop from $2.7 billion in 2010 to $1.9 ...
-
-
A proprietary aerosol formulation of levofloxacin, Aeroquin is currently in Phase 3 clinical trials for the treatment of pulmonary infections in patients with cystic fibrosis (CF). All assets not associated with Aeroquin™, including financial and human ...
-
-
Johnson & Johnson ( $JNJ ) failed to persuade a South Carolina jury that a now notorious "Risperdal letter" did not violate consumer protection statutes. Jurors decided that J&J's Ortho-McNeil-Janssen Pharmaceuticals' 2003 letter to doctors, which depicted ...
-
-
David Livermore is in a race against evolution. In his north London lab, he holds up an evil-smelling culture plate smeared with bacteria. This creamy-yellow growth is the enemy: a new strain of germs resistant to the most powerful antibiotics yet devised ...
-
-
"I used to take prescription drugs, but they zombied me out ... admits to being a little nervous about her for-profit medical marijuana edible business, The Herbal Chef, but has only praise for the Metropolitan Police. "I was threatened by somebody ...
-
-
Uncomplicated urinary tract infections should be treated first with narrow-spectrum drugs (Bactrim is an example), the guidelines say, rather than broad-spectrum ones like Cipro or Levaquin. Broad-spectrum antibiotics tend to wipe out all the bacteria in ...
-
-
XenoPort announced preliminary results from a Phase 2b clinical trial of arbaclofen placarbil (AP) as adjunctive therapy in patients with gastroesophageal reflux disease (GERD) who do not experience complete relief of GERD symptoms while being treated with ...
-
-
"The exposure ratio of torezolid into the ELF versus plasma was above values reported for linezolid, the first generation oxazolidinone, as well as above those reported for quinolone antibiotics, such as levofloxacin which is a mainstay of therapy for ...
-
-
Mpex is in the final stage of clinical testing of a proprietary inhalable formulation of levofloxacin for the treatment of microbial infections in patients with cystic fibrosis. The company's mission is to develop important new therapies to combat the ...
-
-
Toronto, ON : "The first day that I took Levaquin (earlier this year for a slight sinus infection), I woke up later that night to a high-pitched ringing in my head—I thought it was the fire alarm," says Marcia, a ballet teacher. "I jumped out of bed but ...
-
-
I can understand their logic: If it ain’t in the big blue book, it’s OK by me. I interviewed 73-year-old Carol (not her real name) yesterday—yet another Levaquin victim. (BTW, I –personally–must have interviewed dozens of Levaquin victims in the ...
-
-
State and federal court trials are scheduled to begin in April and May, respectively, for claims over tendon ruptures from Levaquin , an antibiotic made by Johnson & Johnson. More than 2,500 Levaquin lawsuits have been filed on behalf of individuals who ...
-
-
(RTTNews) - Hi-Tech Pharmacal Co., Inc. (HITK: News ) said it has acquired the rights to the Abbreviated New Drug Application, or ANDA, for Nystatin Oral suspension from Bausch + Lomb, the global eye health company for an undisclosed upfront payment and a ...
Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.
Pages:
1
2
3
4
5
6
...
Next
|
|
